A detailed history of Twin Peaks Wealth Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Twin Peaks Wealth Advisors, LLC holds 2,885 shares of GILD stock, worth $267,064. This represents 0.11% of its overall portfolio holdings.

Number of Shares
2,885
Holding current value
$267,064
% of portfolio
0.11%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$66.59 - $83.99 $192,112 - $242,311
2,885 New
2,885 $242 Million
Q1 2024

Apr 23, 2024

SELL
$71.58 - $87.29 $14,101 - $17,196
-197 Reduced 6.16%
3,000 $220 Million
Q4 2023

Jan 17, 2024

BUY
$73.27 - $83.09 $234,244 - $265,638
3,197 New
3,197 $259 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Twin Peaks Wealth Advisors, LLC Portfolio

Follow Twin Peaks Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Peaks Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Twin Peaks Wealth Advisors, LLC with notifications on news.